Aug 29, 2011 08:20 EDT nxt2b (Nexttobe AB) an investment company owned by Bengt Ågerup, has today signed an agreement with a group of shareholders in Olink AB to purchase 49 % of the outstanding shares in the company. The intention is to accelerate the growth and value creation of the company by injecting knowledge, experience and financial strength to complement Olink’s unique product and technology position.
Download
Categorization
- Topics:
- Research,
- Health, Health Care, Pharmaceuticals,
- Medicine,
- Medical research,
- Science, technology


Add commentThe comment was saved
Prior to publication, it must be approved by Olink Bioscience.